Puromycin Hydrochloride
Puromycin Hydrochloride - Related Videos
10:36
In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
0 Views •
Cited by 6 •
2017
Maintaining blood-brain barrier coverage is key for the homeostasis of the central nervous system. This protocol describes in vitro techniques to delineate the fundamental and pathological processes that modulate blood-brain barrier coverage.
09:13
Quantitative Immunofluorescence to Measure Global Localized Translation
0 Views •
Cited by 4 •
2017
This manuscript describes a method to visualize and quantify localized translation events in subcellular compartments. The approach proposed in this manuscript requires a basic confocal imaging system and reagents and is rapid and cost-effective.
03:33
Generating Conditional Knockdown Cells Using a Tetracycline-Responsive Lentiviral shRNA Expression System
0 Views •
2026
Source: Kubala, M. H. & DeClerck, Y. A. Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment. J. Vis. Exp. (2017)This video demonstrates the generation of conditional knockdown cancer cell lines using a Tet-inducible lentiviral shRNA system. It outlines the steps for viral transduction, antibiotic selection, and doxycycline-induced gene silencing.
12:25
Epigenome-Wide CRISPR-Cas9-Based Knockout Screens on Chemoresistant Cells
0 Views •
2026
Here, we present a protocol for generating chemoresistant cells using a dose-escalation approach, followed by a CRISPR/Cas9-based screen using a focused sgRNA library targeting epigenetic modifiers to identify regulators of acquired chemoresistance. The protocol also provides multiple optimization points tailored to chemoresistant cell models, offering a robust framework for researchers investigating resistance mechanisms.
02:55
Genetically Modifying CAR T Cells Using a CRISPR-Cas9 System
0 Views •
2025
The video outlines a process for creating genetically modified CAR T cells through the CRISPR-Cas9 System. Infecting T cells with CRISPR and CAR lentiviruses results in modifications to the target gene and the synthesis of a chimeric antigen receptor or CAR, ultimately leading to the formation of genetically modified CAR T cells.
FAQs
Puromycin’s structural resemblance to the aminoacyl end of transfer RNA allows it to access the ribosome’s aminoacyl-tRNA site. Once accepted there, it becomes attached to the growing polypeptide and interrupts elongation by producing a prematurely terminated chain. This mechanism directly links ribosome-level interference to the loss of full-length protein production in treated cells.
The hydrochloride form is important because it is water-soluble, making puromycin suitable for use in aqueous experimental systems. Its formulation supports practical use in biomedical research, while the relevant cellular activity comes from the parent antibiotic’s ability to enter the aminoacyl-tRNA site and terminate growing chains. This separates handling properties from the mechanism of translation inhibition.
Premature termination can produce rapid loss of viable cells because protein synthesis is interrupted while polypeptides are still being made. The resulting disturbance is also useful experimentally: investigators can examine cellular responses to proteotoxic stress, meaning stress associated with disrupted protein handling. Thus, cell killing and stress-response analysis arise from the same translation-blocking event.
Selection experiments typically begin by delivering a genetic construct that includes a puromycin-resistance gene into mammalian cells. Puromycin hydrochloride is then used to challenge the culture, so cells lacking the resistance trait are eliminated while resistant cells remain. Surviving cells provide a practical way to enrich for cells that received and express the intended construct.
Rather than merely showing that cells were exposed to a treatment, puromycin selection links survival to the presence of a resistance gene. The surviving population can therefore support verification of gene delivery and development of genetically modified mammalian cell models. In medicine-related research, this provides a functional selection outcome associated with the intended genetic modification.
Puromycin hydrochloride supports several complementary research uses. In cell biology, it helps generate genetically modified mammalian cell populations; in translational studies, it provides a way to probe how protein synthesis is controlled; and in drug-related work, its defined effect helps investigate responses to translation disruption and proteotoxic stress. These applications connect selection with mechanistic experiments.